Global Rapid Influenza Diagnostic Tests Market to cross $ 689 Mn by 2025

January 08, 2020


According to the research report titled ‘Rapid Influenza Diagnostic Tests (RIDT) Market Size By Product (RIDT for Influenza A, RIDT for Influenza B), By Patient (Pediatric, Adult), By End-use (Hospitals, Diagnostics Centers, Research Laboratories) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available at MarketStudyReport.com, the global rapid influenza diagnostic tests (RIDT) market is expected to surpass USD 689 million by the year 2025.
 

According to the report, increasing frequency of viral infections and infectious diseases across the globe is a major factor driving the RIDT market growth. These tests are not only used to diagnose but also to treat highly contagious diseases which spread through physical contact or airborne routes. RIDT offers accurate identification and diagnosis of various viral infections.
 

Increasing awareness regarding RIDT advantages among elderly population is also aiding the market expansion. However, strict government regulations regarding the approval of new kits may hinder the growth of the RIDT market.
 

As per product type, the report states that RIDT for Influenza A segment amassed 352.5 million in 2018 and will register continuous growth during the forecast period. Rising elderly population, growing occurrence of infectious diseases, and increasing diagnosis and treatments for influenza are contributing towards the popularity of the product across the globe.
 

In terms of patient type, the pediatric segment is presumed to grow with a CAGR of 7.5 % during the estimated timeframe. Rising prevalence of influenza among pediatric population is stimulating the industry outlook.
 

By end-use, the report cites that influenza diagnostic centers segment was worth USD 171.5 million in the year 2018. Advancement in healthcare infrastructure in tandem with increasing awareness pertaining to advantages of specialized devices are fueling the segmental growth.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2270767/
 

As per regional analysis, India RIDT market amassed a market valuation of 15.1 million in the year 2018 and is expected to show consistent growth during the projected timeline. Growing occurrence of influenza is facilitating the business scenario in the country. Meanwhile, Canada RIDT market is estimated to grow with a CAGR of 7.3% during 2019-2025. High rate of hospitalization in consort with rising awareness pertaining to prevention of common cold, flu, and contagious diseases are augmenting the demand for RIDT kits across the country.
 

Princeton BioMeditech Corp., Quidel Corp., Roche, Analytik Jena, Abbott, Meridian Bioscience Inc., CorisBioconcep., SA Scientific, Becton, Dickinson & Co. and DiaSorin S.p.A are the prominent companies operating in RIDT market.


Frequently Asked Questions (FAQ) :

Increasing frequency of viral infections and infectious diseases across the globe is a major factor driving the RIDT market growth. These tests are not only used to diagnose but also to treat highly contagious diseases which spread through physical contact or airborne routes. RIDT offers accurate identification and diagnosis of various viral infections. Increasing awareness regarding RIDT advantages among elderly population is also aiding the market expansion.
The report states that RIDT for Influenza A segment amassed 352.5 million in 2018 and will register continuous growth during the forecast period. Rising elderly population, growing occurrence of infectious diseases, and increasing diagnosis and treatments for influenza are contributing towards the popularity of the product across the globe.
India RIDT market amassed a market valuation of 15.1 million in the year 2018 and is expected to show consistent growth during the projected timeline. Growing occurrences of influenza is facilitating the business scenario in the country. Meanwhile, Canada RIDT market is estimated to grow with a CAGR of 7.3% during 2019-2025. High rate of hospitalization in consort with rising awareness pertaining to prevention of common cold, flu, and contagious diseases are augmenting the demand for RIDT kits across the country.
Princeton BioMeditech Corp., Quidel Corp., Roche, Analytik Jena, Abbott, Meridian Bioscience Inc., CorisBioconcep., SA Scientific, Becton, Dickinson & Co. and DiaSorin S.p.A are the prominent companies operating in RIDT market.